Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson's disease
Neural Regen Res
.
2022 Aug;17(8):1743-1744.
doi: 10.4103/1673-5374.332143.
Authors
Rafael A Garcia-Munoz
1
,
Joseph McConnell
2
,
Victoria Morales
1
,
Raul Sanz
1
Affiliations
1
Department of Chemical and Environmental Technology, Rey Juan Carlos University, Madrid, Spain.
2
Department of Chemical & Process Engineering, University of Strathclyde, Glasgow, UK.
PMID:
35017428
PMCID:
PMC8820718
DOI:
10.4103/1673-5374.332143
No abstract available